[HT942526RCRPIDA] DoW Rare Cancers Idea Development Award

Description

Titolo: DoW Rare Cancers Idea Development Award Numero dell'opportunità: HT942526RCRPIDA Stato: aperto (posted) Tipo di opportunità: Discretionary Ente: Defense Health Agency Contracting Activity - DHACA — Department of Defense Tipo di finanziamento: Grant Categoria: Science and Technology and other Research and Development Programma (ALN): 12.420 Military Medical Research and Development Pubblicato il: 2026-06-17 Scadenza per le domande: 2026-11-18 Finanziamento totale stimato: 7,350,000 USD Numero di finanziamenti attesi: 15 Cofinanziamento richiesto: no Chi può fare domanda: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" Descrizione: Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Idea Development Award (IDA) promotes ideas that are ready for further development and have the potential to yield high-impact findings and new avenues of investigation. Distinctive Features: The RCRP encourages applicants to include an exploratory aim or sub-aim to support any necessary discovery-driven research. Preliminary data with disease-specific rationale are required. However, these data do not necessarily need to originate from studies of the proposed rare cancer type(s)/subtype(s) under study. Research should have high potential impact on rare cancers and the patient community. Contatto: [email protected]

Sectors

Source

Source: grants.gov